Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Plos One
|
April 10, 2015
Perioperative chemotherapy in gastroesophageal cancer. A retrospective monocenter evaluation of 42 cases
Ann-Christin E Brehler, Wolfgang Hartmann, Stefanie Wiebe, et al.
Cancers
|
July 2, 2021
Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers
Evgenii Shumilov, Petra Hoffknecht, Raphael Koch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials
Paul J Bröckelmann, Helen Goergen, Charlotte Kohnhorst, et al.
Annals of Hematology
|
May 1, 2012
POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience
Gabriela B Thoennissen, Nils H Thoennissen, Fleur Fritz, et al.
Annals of Hematology
|
March 21, 2015
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease
Linus Angenendt, Andrea Kerkhoff, Stefanie Wiebe, et al.
Leukemia & Lymphoma
|
March 29, 2021
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy
Daniela V Wenge, Klaus Wethmar, Jan-Henrik Mikesch, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report
Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Annals of Hematology
|
May 24, 2020
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
Christine Eisfeld, Eva Eßeling, Ramona Wullenkord, et al.
Cold Spring Harbor Molecular Case Studies
|
July 7, 2017
Metastatic triple-negative breast cancer patient with <i>TP53</i> tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events
Tobias Meißner, Adam Mark, Casey Williams, et al.
Blood
|
February 3, 2016
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials
Boris Böll, Helen Goergen, Karolin Behringer, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Plos One
|
April 10, 2015
Perioperative chemotherapy in gastroesophageal cancer. A retrospective monocenter evaluation of 42 cases
Ann-Christin E Brehler, Wolfgang Hartmann, Stefanie Wiebe, et al.
Cancers
|
July 2, 2021
Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers
Evgenii Shumilov, Petra Hoffknecht, Raphael Koch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials
Paul J Bröckelmann, Helen Goergen, Charlotte Kohnhorst, et al.
Annals of Hematology
|
May 1, 2012
POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience
Gabriela B Thoennissen, Nils H Thoennissen, Fleur Fritz, et al.
Annals of Hematology
|
March 21, 2015
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease
Linus Angenendt, Andrea Kerkhoff, Stefanie Wiebe, et al.
Leukemia & Lymphoma
|
March 29, 2021
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy
Daniela V Wenge, Klaus Wethmar, Jan-Henrik Mikesch, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report
Carolin Krekeler, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Annals of Hematology
|
May 24, 2020
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
Christine Eisfeld, Eva Eßeling, Ramona Wullenkord, et al.
Cold Spring Harbor Molecular Case Studies
|
July 7, 2017
Metastatic triple-negative breast cancer patient with <i>TP53</i> tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events
Tobias Meißner, Adam Mark, Casey Williams, et al.
Blood
|
February 3, 2016
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials
Boris Böll, Helen Goergen, Karolin Behringer, et al.
Page
of 5